BMJ Evidence-Based Medicine: 28 (2)

Editorial

Improving FDA postmarket adverse event reporting for medical devices (17 February, 2022)
Susmitha Wunnava, Timothy A Miller, Florence T Bourgeois
Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis (12 August, 2022)
Thanya Pathirana, Yu Wang, Frederik Martiny, Tessa Copp, Raman Kumar, Kumara Mendis, Jinling Tang

Primary care: Validity and reliability of the Spanish version of the ACE tool for assessing competencies in evidence-based medicine in medical students (23 September, 2022)
Nadia Sgarbossa, Sofia Marino, Lucas Aletta, Fernando Ramón Vázquez Peña, Juan Victor Ariel Franco
Consistency between trials presented at conferences, their subsequent publications and press releases (10 November, 2022)
Anisa Rowhani-Farid, Kyungwan Hong, Mikas Grewal, Jesse Reynolds, Audrey D Zhang, Joshua D Wallach, Joseph S Ross
Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study (8 December, 2022)
Mark J Gibson, Francesca Spiga, Amy Campbell, Jasmine N Khouja, Rebecca C Richmond, Marcus R Munafò
Swallowing outcomes in dysphagia interventions in Parkinson’s disease: a scoping review (11 November, 2022)
Julia Hirschwald, Jule Hofacker, Sallyanne Duncan, Margaret Walshe
Retrieval barriers in individual participant data reviews with network meta-analysis (21 December, 2022)
Areti Angeliki Veroniki, Lesley A Stewart, Susan P C Le, Mike Clarke, Andrea C Tricco, Sharon E Straus
Different meta-analysis methods can change judgements about imprecision of effect estimates: a meta-epidemiological study (2 February, 2023)
Zhen Wang, Muayad A Alzuabi, Rebecca L Morgan, Reem A Mustafa, Yngve Falck-Ytter, Philipp Dahm, Shahnaz Sultan, Mohammad Hassan Murad

In memory of Richard Saitz (1963–2022): former editor of BMJ Evidence-Based Medicine (8 April, 2022) Free
Denise Campbell-Scherer, Khalid Khan, Joshua Fenton, Caroline J Kistin